Market Cap | 259.26M | P/E | - | EPS this Y | -3.70% | Ern Qtrly Grth | - |
Income | -50.71M | Forward P/E | 38.09 | EPS next Y | 182.10% | 50D Avg Chg | -1.00% |
Sales | 187.51M | PEG | -3.22 | EPS past 5Y | -5.43% | 200D Avg Chg | -13.00% |
Dividend | N/A | Price/Book | 2.68 | EPS next 5Y | 10.00% | 52W High Chg | -27.00% |
Recommedations | 1.30 | Quick Ratio | 0.54 | Shares Outstanding | 29.60M | 52W Low Chg | 15.00% |
Insider Own | 1.88% | ROA | -1.68% | Shares Float | 18.29M | Beta | 1.10 |
Inst Own | 85.33% | ROE | -34.88% | Shares Shorted/Prior | 357.35K/546.02K | Price | 8.76 |
Gross Margin | 24.40% | Profit Margin | -53.34% | Avg. Volume | 64,265 | Target Price | 13.75 |
Oper. Margin | -5.23% | Earnings Date | Apr 3 | Volume | 52,474 | Change | -3.52% |
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Bolles Albert D. | Chief Executive Offi.. Chief Executive Officer | May 23 | Option | 9.45 | 55,000 | 519,750 | 100,152 | 05/24/22 |
WYNNEFIELD PARTNERS SMALL CAP... | 10% Owner 10% Owner | Jan 12 | Buy | 10.41 | 387,400 | 4,032,834 | 2,008,694 | 01/14/22 |
Schechter Joshua | Director Director | Jan 12 | Buy | 10.4 | 10,000 | 104,000 | 2,000 | 01/14/22 |
McLaughlin Brian F | Chief Financial Offi.. Chief Financial Officer | Oct 20 | Option | 10.09 | 5,000 | 50,450 | 19,532 | 10/20/20 |
OBUS NELSON | Director Director | Oct 15 | Buy | 10.26 | 10,000 | 102,600 | 2,885,300 | 10/15/20 |